Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Research Article

The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer

Author(s): Marc Ingenwerth, Péter Nyirády, Boris Hadaschik, Tibor Szarvas* and Henning Reis*

Volume 22, Issue 10, 2022

Published on: 25 March, 2022

Page: [941 - 949] Pages: 9

DOI: 10.2174/1566524021666210225100041

Price: $65

conference banner
Abstract

Background: Expression levels of collagens have been implicated in the progression of various cancers and interaction with cytokeratins but are not well studied in bladder cancer (BC). Therefore, we analyzed the gene and protein expression levels of collagen 1A1 (Col1a1/COL1A1), collagen 3A1 (col3a1/COL3A1), collagen 5A2 (col5a2/COL5A2), cytokeratin 14 (krt14/CK14), and cytokeratin 17 (krt17/CK17) in urothelial BC samples of different stages.

Methods: In total, 102 fresh frozen and 190 formalin-fixed and paraffin-embedded (FFPE) samples were tested using immunohistochemistry and RT-qPCR. Expression levels were correlated with clinicopathological and follow-up data.

Results: Col1a1, col3a1, col5a2 and krt14 mRNA levels were significantly overexpressed in high-grade and muscle-invasive BC (MIBC) compared to low-grade and non-muscle invasive BC (NMIBC) cases. Disease-specific survival (DSS) was shorter in patients with high expression levels of col1a1 (p = 0.004), col3a1 (p = 0.004), and col5a2 (p = 0.028). CK14 (p = 0.020), COL3A1 (p = 0.006), and Col5A2 (p = 0.006) protein expression levels were significantly higher and protein expression levels of CK17 (p = 0.05) were significantly lower in MIBC compared to NMIBC. Furthermore, CK14 (p = 0.002) and COL5A2 (p = 0.006) protein expression level were significantly higher in high-grade compared to low-grade BC. DSS was shorter in patients with high expression levels of COL5A2 (p = 0.033) and CK14 (p = 0.042).

Conclusion: Expression changes of collagens and cytokeratins are univariable prognostic markers in BC.

Keywords: COL1A1, COL3A1, COL5A2, CK14, CK17, bladder cancer, epithelial-mesenchymal-transition.

« Previous Next »
[1]
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017; 71(1): 96-108.
[http://dx.doi.org/10.1016/j.eururo.2016.06.010] [PMID: 27370177]
[2]
Chalasani V, Chin JL, Izawa JI. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 2009; 3(6)(Suppl. 4): S193-8.
[PMID: 20019984]
[3]
Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49(3): 466-5.
[http://dx.doi.org/10.1016/j.eururo.2005.12.031] [PMID: 16442208]
[4]
Witjes JA, Compérat E, Cowan NC, et al. European Association of Urology. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014; 65(4): 778-92.
[http://dx.doi.org/10.1016/j.eururo.2013.11.046] [PMID: 24373477]
[5]
Samaratunga H, Fairweather P, Purdie D. Significance of stromal reaction patterns in invasive urothelial carcinoma. Am J Clin Pathol 2005; 123(6): 851-7.
[http://dx.doi.org/10.1309/EE8RTB6X1611G6TU] [PMID: 15899775]
[6]
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19(11): 1423-37.
[http://dx.doi.org/10.1038/nm.3394] [PMID: 24202395]
[7]
Paterson RF, Ulbright TM, MacLennan GT, et al. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 2003; 98(9): 1830-6.
[http://dx.doi.org/10.1002/cncr.11747] [PMID: 14584063]
[8]
Enkelmann A, Heinzelmann J, von Eggeling F, et al. Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer. J Cancer Res Clin Oncol 2011; 137(5): 751-9.
[http://dx.doi.org/10.1007/s00432-010-0932-6] [PMID: 20607552]
[9]
Wang HB, Dembo M, Wang YL. Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. Am J Physiol Cell Physiol 2000; 279(5): C1345-50.
[http://dx.doi.org/10.1152/ajpcell.2000.279.5.C1345] [PMID: 11029281]
[10]
Li J, Ding Y, Li A. Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer. World J Surg Oncol 2016; 14(1): 297.
[http://dx.doi.org/10.1186/s12957-016-1056-5] [PMID: 27894325]
[11]
Boguslawska J, Kedzierska H, Poplawski P, Rybicka B, Tanski Z, Piekielko-Witkowska A. Expression of genes involved in cellular adhesion and extracellular matrix remodeling correlates with poor survival of patients with renal cancer. J Urol 2016; 195(6): 1892-902.
[http://dx.doi.org/10.1016/j.juro.2015.11.050] [PMID: 26631499]
[12]
Wang Y, Resnick MB, Lu S, et al. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast. Hum Pathol 2016; 57: 176-81.
[http://dx.doi.org/10.1016/j.humpath.2016.07.017] [PMID: 27498063]
[13]
Fischer H, Stenling R, Rubio C, Lindblom A. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001; 22(6): 875-8.
[http://dx.doi.org/10.1093/carcin/22.6.875] [PMID: 11375892]
[14]
Kamoun A, de Reyniès A, Allory Y, et al. Bladder cancer molecular taxonomy group. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 2020; 77(4): 420-33.
[http://dx.doi.org/10.1016/j.eururo.2019.09.006] [PMID: 31563503]
[15]
Ho PL, Kurtova A, Chan KS. Normal and neoplastic urothelial stem cells: getting to the root of the problem. Nat Rev Urol 2012; 9(10): 583-94.
[http://dx.doi.org/10.1038/nrurol.2012.142] [PMID: 22890301]
[16]
Papafotiou G, Paraskevopoulou V, Vasilaki E, Kanaki Z, Paschalidis N, Klinakis A. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat Commun 2016; 7: 11914.
[http://dx.doi.org/10.1038/ncomms11914] [PMID: 27320313]
[17]
Volkmer JP, Sahoo D, Chin RK, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci USA 2012; 109(6): 2078-83.
[http://dx.doi.org/10.1073/pnas.1120605109] [PMID: 22308455]
[18]
Guelstein VI, Tchipysheva TA, Ermilova VD, Troyanovsky SM. Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 64(1): 1-5.
[http://dx.doi.org/10.1007/BF02915089] [PMID: 7691361]
[19]
Tschirdewahn S, Reis H, Niedworok C, et al. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urol Oncol 2014; 32(5): 663-9.
[http://dx.doi.org/10.1016/j.urolonc.2014.02.004] [PMID: 24814404]
[20]
Brooks M, Mo Q, Krasnow R, et al. Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget 2016; 7(50): 82609-19.
[http://dx.doi.org/10.18632/oncotarget.12089] [PMID: 27655672]
[21]
Pudova EA, Kudryavtseva AV, Fedorova MS, et al. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer. BMC Genomics 2018; 19(Suppl. 3): 113.
[http://dx.doi.org/10.1186/s12864-018-4477-4] [PMID: 29504907]
[22]
Zhang Z, Wang Y, Zhang J, Zhong J, Yang R. COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway. Mol Med Rep 2018; 17(4): 5037-42.
[http://dx.doi.org/10.3892/mmr.2018.8533] [PMID: 29393423]
[23]
Yuan L, Shu B, Chen L, et al. Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis. Oncotarget 2017; 8(41): 70508-20.
[http://dx.doi.org/10.18632/oncotarget.19733] [PMID: 29050298]
[24]
Su B, Zhao W, Shi B, et al. Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Mol Cancer 2014; 13: 206.
[http://dx.doi.org/10.1186/1476-4598-13-206] [PMID: 25193015]
[25]
Zeng XT, Liu XP, Liu TZ, Wang XH. The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data. Medicine (Baltimore) 2018; 97(10)e0091
[http://dx.doi.org/10.1097/MD.0000000000010091] [PMID: 29517678]
[26]
Vargas AC, McCart Reed AE, Waddell N, et al. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat 2012; 135(1): 153-65.
[http://dx.doi.org/10.1007/s10549-012-2123-4] [PMID: 22718308]
[27]
Nissen NI, Karsdal M, Willumsen N. Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology. J Exp Clin Cancer Res 2019; 38(1): 115.
[http://dx.doi.org/10.1186/s13046-019-1110-6] [PMID: 30841909]
[28]
Coulson-Thomas VJ, Coulson-Thomas YM, Gesteira TF, et al. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res 2011; 346(2): 223-36.
[http://dx.doi.org/10.1007/s00441-011-1254-y] [PMID: 21987222]
[29]
Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder. Cancer Cell 2017; 171(3): 540-56 e25.
[http://dx.doi.org/10.1016/j.cell.2017.09.007]
[30]
Kim SP, Frank I, Cheville JC, et al. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol 2012; 188(2): 405-9.
[http://dx.doi.org/10.1016/j.juro.2012.04.020] [PMID: 22704101]
[31]
Mitra AP, Bartsch CC, Bartsch G Jr, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol 2014; 32(2): 117-27.
[http://dx.doi.org/10.1016/j.urolonc.2012.08.017] [PMID: 23477878]
[32]
Bertucci F, Finetti P, Birnbaum D. Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med 2012; 12(1): 96-110.
[http://dx.doi.org/10.2174/156652412798376134] [PMID: 22082486]
[33]
Choi W, Porten S, Kim S, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 2014; 25(2): 152-65.
[http://dx.doi.org/10.1016/j.ccr.2014.01.009] [PMID: 24525232]

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy